Drug Recall
Terminated
Historical recordClass II
Buprenorphine HCI Injection, 0.3 mg/mL, 1 mL Single Dose Vial (NDC 42023-179-01), packaged in 1 mL x 5 Single Dose Vials per carton (NDC 42023-179-05), Rx Only, Distributed by: Par Pharmaceuticals Companies, Inc., Spring Valley, NY 10977.
by Par Sterile Products LLC
- Reason
- Crystallization: due to the presence of white, crystalline particulates, adhered to the side and bottom of the glass vials, which are comprised of principally dextrose and the buprenorphine active component.
- Recall initiated
- April 28, 2017
- Reported by FDA
- May 17, 2017
- Distribution
- Nationwide in the USA
View recall →
Drug Recall
Terminated
Historical recordClass III
IC-Green (indocyanine green for injection, USP), 25 mg, packaged in a kit containing six vials of 25 mg lyophilized powder, Rx only, Manufactured by: Akorn, Inc., NDC 17478-701-02
by Akorn, Inc.
- Reason
- Product is being recalled due to low pH value.
- Recall initiated
- April 20, 2017
- Reported by FDA
- May 17, 2017
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Sulfamethoxazole and Trimethoprim Oral Suspension, USP 200 mg / 40 mg per 5 mL , Grape Flavor, Rx Only, 16 fl oz. (473 mL), HI-TECH PHARMACAL CO., INIC, Amityville, NY 11701, NDC 50383-824-16
by Akorn Inc
- Reason
- Failed Dissolution Specifications
- Recall initiated
- March 13, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass III
Zinc Oxide Paste 25%, 500 g, For Prescription Compounding, Fagron Inc.2400 Pilot Knob Rd, St. Paul, MN 55120m NDC 51522-0694-5.
by Fagron, Inc
- Reason
- Labeling: Error on Declared Strength: Error is due to an incorrect value in the Drug Facts Panel. The correct strength is displayed on the primary container.
- Recall initiated
- April 17, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide within US
View recall →
Drug Recall
Terminated
Historical recordClass III
Allergy Relief Diphenhydramine HCl 25 mg, Antihistamine, Dye-Free, 24 Softgels, distributed under the following labels: (a) TopCare Allergy Relief, DISTRIBUTED BY TOPCO ASSOCIATES LLC, ELK GROVE VILLAGE, IL 60007, NDC 36800-483-24, UPC 0-36800-39134-5; (b) Rexall Since 1903 Allergy Relief, PACKAGED FOR DOLGENCORP, LLC, 100 MISSION RIDGE GOODLETTSVILLE, TN 37072, UPC 3-59726-72025-0; (c) HyVee health Allergy Relief, DISTRIBUTED BY HY-VEE, INC. 5820 WESTOWN PARKWAY, WEST DES MOINES, IA 50266, NDC 42507-483-24, UPC 0-75450-12369-2; (d) up & up allergy relief, Distributed by Target Corporation, Minneapolis, MN 55403, NDC 11673-720-24, UPC 3-59726-72025-0; (e) smart sense allergy softgels, Distributed by Kmart Corporation, Hoffman Estates, IL 60179, NDC 49738-483-24, UPC 8-83967-39839-3.
by P & L Development, LLC
- Reason
- Subpotent: This product is being recalled due to low out of specification assay results at the 9 month time point.
- Recall initiated
- April 17, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide
View recall →
Drug Recall
Terminated
Historical recordClass II
Rabeprazole Sodium Delayed Release Tablets, 20 mg, a) 30-count bottle (NDC 65162-0724-03), b) 90-count bottle (NDC 65162-0724-09), Rx Only, Manufactured by Amneal Pharmaceuticals Pvt. Ltd., Ahmedabad INDIA 382220, Distributed by Amneal Pharmaceuticals, Bridgewater, NJ 08807
by Amneal Pharmaceuticals LLC
- Reason
- Failed Dissolution Specifications
- Recall initiated
- December 12, 2016
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide within the US and PR
View recall →
Drug Recall
Terminated
Historical recordClass III
Aripiprazole Tablets, 2 mg, 30 count unit dose box, Rx only, Manufactured by Apotex Inc., Toronto, Ontario, Canada, Distributed by Major Pharmaceuticals, Livonia, MI NDC 0904-6509-04
by The Harvard Drug Group
- Reason
- Superpotent Drug; out of specification results for assay (manufacturer)
- Recall initiated
- December 27, 2016
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide and PR
View recall →
Drug Recall
Ongoing
Historical recordClass I
EpiPen Jr. 2-Pak (Epinephrine) Auto-Injectors 0.15 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS: Epipen Auto-Injector Jr. 0.15 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.
by Meridian Medical Technologies a Pfizer Company
- Reason
- Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication
- Recall initiated
- March 12, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.
View recall →
Drug Recall
Ongoing
Historical recordClass I
EpiPen 2-Pak (Epinephrine) Auto-Injectors 0.3 mg, Rx only, Manufactured for Mylan Specialty L.P., Morgantown WV 26505 by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company; NDC 49502-500-02 ---- ALSO LABELED OUTSIDE THE US AS ---- Epipen Auto-Injector 0.3 mg -Bright Stock labeled for multiple countries- manufactured for Mylan by Meridian Medical Technologies, Inc., Columbia, MD 21046, a Pfizer company.
by Meridian Medical Technologies a Pfizer Company
- Reason
- Defective Delivery System; reports of the device failing to activate which could result in a patient not receiving medication
- Recall initiated
- March 12, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide and Puerto Rico, Argentina, Austria, Australia, Belgium, Chile, Croatia, Czech Republic, Denmark, Estonia, Finland, France, Germany, Ireland, Italy, Japan, Latvia, Lithuania, Netherlands, New Zealand, Norway, Poland, Portugal, Romania, Saudi Arabia, Singapore, Slovakia, Slovenia, Sweden, Switzerland, Taiwan, Thailand, United Kingdom. There has been no U.S. government or military distribution.
View recall →
Drug Recall
Terminated
Historical recordClass II
Fluconazole Tablets, USP, 200 mg, 100-count Unit Dose carton, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Distributed by MAJOR PHARMACEUTICALS, 31778 Enterprise Dr., Livonia, MI 48150 USA, NDC 0904-6501-61
by The Harvard Drug Group
- Reason
- Failed Dissolution Specifications
- Recall initiated
- January 5, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide within the US
View recall →
Drug Recall
Terminated
Historical recordClass II
Fluconazole Tablets, USP, 100 mg, 100-count Unit Dose carton, Rx only, Manufactured by Dr. Reddy's Laboratories Limited, Bachupally - 500 090 INDIA, Distributed by MAJOR PHARMACEUTICALS, 31778 Enterprise Dr., Livonia, MI 48150 USA, NDC 0904-6500-61
by The Harvard Drug Group
- Reason
- Failed Dissolution Specifications
- Recall initiated
- January 5, 2017
- Reported by FDA
- May 10, 2017
- Distribution
- Nationwide within the US
View recall →
Drug Recall
Terminated
Historical recordClass II
Phenylephrine 2.5%, Tropicamide 1%, 15 mL Multi-Dose Ophthalmic (spelled Opthalmic) Drops in a bottle, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1300, barcode 3 70285 13001 4.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass II
Testosterone Cypionate 200 mg/mL, Testosterone Propionate 20 mg/mL, 30 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1200, barcode 3 70285 12003 9.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass II
Cyanocobalamin 1 mg/mL/ Methionine 25 mg/mL/ Inositol 50 mg/mL/ Choline 50 mg/mL, 30 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1101, barcode 3 70285 11013 9.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass II
Triamcinolone Diacetate 40 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1021, barcode 3 70285 10211 0.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass II
Triamcinolone Acetonide 40 mg/mL, Lidocaine HCl 10 mg/mL , 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1020, barcode 3 70285 10201 1.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylprednisolone Acetate 80 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Dr, SLC, UT 84109, Part # 1011, barcode 3 70285 10111 3.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass II
Methylprednisolone Acetate 40 mg/mL, Lidocaine HCl 10 mg/mL, 10 mL Multi-Dose Vial For Injection, Rx Only, Isomeric Pharmacy Solutions, 2401 Foothill Drive, SLC, UT 84109, Part # 1010, barcode 3 70285 10101 4.
by Isomeric Pharmacy Solution, LLC
- Reason
- Lack of Assurance of Sterility: due to concerns with production processes which cannot assure sterility of products intended to be sterile.
- Recall initiated
- April 6, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- Nationwide in the USA and Puerto Rico
View recall →
Drug Recall
Terminated
Historical recordClass III
Donepezil HCl tablets, 10mg, packaged in 10x10 blister packs per carton (100 Unit Dose) container, Rx only, Manufactured by Sandoz, Inc., 506 Carnegie Center, Suite 400, Princeton, NJ 08805, Distributed by: McKesson Packaging Services, 7101 Weddington Rd, Concord, NC 28027, NDC 63739-678-10
by Mckesson Packaging Services
- Reason
- Supotent: Out of Specification result for assay test during routine stability testing.
- Recall initiated
- January 4, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- CO, LA and OH.
View recall →
Drug Recall
Terminated
Historical recordClass III
Pilocarpine Hydrochloride Ophthalmic Solution 4% , packaged in 15 mL bottles, Rx Only, Manufactured by Alcon Laboratories, Inc. Fort Worth, Texas 76134 Sandoz Princeton, NJ 08540, NDC 61314-206-15
by Novartis Pharmaceuticals Corp.
- Reason
- Failed Impurities/Degradation Specifications.
- Recall initiated
- March 22, 2017
- Reported by FDA
- May 3, 2017
- Distribution
- nationwide
View recall →
This information is republished from FDA's Recall Enterprise System through openFDA. Public Health Trace
does not verify or supplement it, is not affiliated with the FDA, and does not provide medical advice --
always follow the guidance of your pharmacist, physician, or the recalling company for any medication you take.
Read the full medical disclaimer.